Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05415007

GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer

Brief Intervention to Reduce Anxiety and Promote Resilience in Caregivers of Youth With Cancer

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
8 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine a psychotherapeutic and psycho-educational intervention offered in virtual settings to caregivers of youth with cancer. Human subjects must be used because they are the object of the intervention.

Detailed description

PRIMARY OBJECTIVE(S)- To examine the feasibility and accessibility of a brief intervention for caregivers of youth with newly-diagnosed cancer as a preliminary, data-generating step toward applying for a larger NCI R34 grant evaluating the efficacy of the program in a randomized controlled trial. SECONDARY OBJECTIVE(S)- We hope to learn whether a psycho-educational, psychotherapeutic intervention offered in a virtual setting to caregivers of children diagnosed with cancer is feasible, is acceptable, and can prevent, minimize, or improve symptoms of psychological distress (including symptoms of anxiety, depression, and post-traumatic stress disorder). We also hope to further our understanding of family stress and expand the idea for a need of mental health services in pediatric oncology. We aim to further understand intervention strategies for domains of family stress, reducing levels of caregiver anxiety, and promoting resilience for caregivers. This is important because these symptoms can affect the quality of life of caregivers and affect their ability to adhere to their children's treatments.

Conditions

Interventions

TypeNameDescription
BEHAVIORALGOLD ProgramParticipant will receive a 2-hour interventional session
BEHAVIORALTreatment as usual (TAU)Participant will receive treatment-As-Usual which consist of information about diagnosis routinely-disseminated by personnel and providers.

Timeline

Start date
2022-09-21
Primary completion
2026-12-31
Completion
2027-06-30
First posted
2022-06-10
Last updated
2025-07-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05415007. Inclusion in this directory is not an endorsement.